Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- International trends in the incidence of malignant melanoma 1953–2008 – Are recent generations at higher or lower risk?.Int J Cancer. 2013; 132: 385-400
Steliarova-Foucher E, O’Callaghan M, Ferlay J, Masuyer E, Forman D, Comber H, et al. European cancer observatory: cancer incidence, mortality, prevalence and survival in Europe. Version 1.0 (September 2012) European Network of Cancer Registries, International Agency for Research on Cancer. Available from <http://eco.iarc.fr> (accessed on 4/September/2014).
- International prevalence of indoor tanning: a systematic review and meta-analysis.JAMA Dermatol. 2014; 150: 390-400
- Cancer mortality in Europe, 2005–2009, and an overview of trends since 1980.Ann Oncol. 2013; 24: 2657-2671
- Cancer survival increases in Europe, but international differences remain wide.Eur J Cancer. 2001; 37: 1659-1667
- Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5 – A population-based study.Lancet Oncol. 2014; 15: 23-34
- An evidence-based staging system for cutaneous melanoma.CA Cancer J Clin. 2004; 54: 131-149
- When do changes in cancer survival mean progress? The insight from population incidence and mortality.J Natl Cancer Inst Monogr. 2014; 49: 187-197
- Fritz A.G. Percy C. Jack A. International Classification of Diseases for Oncology (ICD-O). 3rd ed. World Health Organization, Geneva2000
- The EUROCARE-5 study on cancer survival in Europe: database, quality checks and methods of statistical analysis.Eur J Cancer. 2015; 51: 2104-2119
- Period analysis for ‘up-to-date’ cancer survival data: theory, empirical evaluation, computational realisation and applications.Eur J Cancer. 2004; 40: 326-335
- Up-to-date long-term survival curves of patients with cancer by period analysis.J Clin Oncol. 2002; 20: 826-832
- Standard cancer patient population for age standardising survival ratios.Eur J Cancer. 2004; 40: 2307-2316
- Instructions to IBM 650 programmers in processing survival computations. Methodological note no. 10.End Results Evaluation Section, National Cancer Institute, Bethesda, MD1959
- Mathematical contributions to the theory of evolution—III. Regression, heredity, and panmixia.Philos Trans R Soc Lond A. 1896; 187: 253-318
SEER Stat Fact Sheets: Melanoma of the Skin. Available from: seer.cancer.govcite [cited 2015 Jul 3].
Australian Government Cancer Australia. Melanoma of the skin statistics [cited 2015 July 3] Available from: <http://www.canceraustralia.gov.au>.
- EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century.Annal Oncol. 2003; 14: v128-v149
- Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe.Eur J Cancer. 2004; 40: 1045-1052
- EUROCARE- 4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary.Eur J Cancer. 2009; 45: 931-991
- Reducing mortality in individuals at high risk for advanced melanoma through education and screening.J Am Acad Dermatol. 2011; 65: s87-s94
- Screening, early detection, education, and trends for melanoma: Current status (2007–2013) and future directions: Part II. Screening, education, and future directions.J Am Acad Dermatol. 2014; 71 (e1–e611.e10): 611
- Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996.J Am Acad Dermatol. 2008; 58: 741-749
- A randomised trial of population screening for melanoma.J Med Screen. 2002; 9: 33-37
- Behavioral determinants of successful early melanoma detection: role of self and physician skin examination.Cancer. 2012; 118: 3725-3734
- Does skin cancer screening save lives? An observational study comparing trends in melanoma mortality in regions with and without screening.Cancer. 2012; 118: 5395-5402
- Clinical whole-body skin examination reduces the incidence of thick melanomas.Int J Cancer. 2010; 126: 450-458
- The melanoma ‘epidemic’: lessons from prostate cancer.J Cutan Pathol. 2012; 39: 17-20
- Melanoma Prevention Working Group—Pigmented Skin Lesion Sub-Committee Survival is not the only valuable end point in melanoma screening.J Invest Dermatol. 2012; 132: 1332-1337
- Skin biopsy rates and incidence of melanoma: population based ecological study.BMJ. 2005; 331: 481
- Cutaneous melanoma in Iceland: changing Breslow’s tumour thickness.J Eur Acad Dermatol Venereol. 2015; 29: 346-352
- Overdiagnosis in cancer.J Natl Cancer Inst. 2010; 102: 605-613
- Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.Eur J Cancer. 2013; 49: 2705-2716
- Socioeconomic and lifestyle factors and melanoma: a systematic review.Br J Dermatol. 2015; 172: 885-915
- Comparative cancer survival in European countries.Br Med Bull. 2014; 110: 5-22
Paolo Baili, Francesca Di Salvo, Rafael Marcos-Gragera, Sabine Siesling, Sandra Mallone, Mariano Santaquilani, et al. Survival for all cancer patients diagnosed between 1999 and 2007 in Europe: results of EUROCARE-5, a population-based study. Eur J Cancer 2015;51:2120–9.
- Cutaneous melanoma.Lancet. 2014; 383: 816-827
- EUROCARE-3: survival of cancer patients diagnosed 1990–94-results and commentary.Ann Oncol. 2003; 14: v61-v118
- Gender differences in melanoma survival: female patients have a decreased risk of metastasis.J Invest Dermatol. 2011; 131: 719-726
- Incidence and survival in patients with cutaneous melanoma by morphology, anatomical site and TNM stage: a Danish Population-based Register Study 1989–2011.Cancer Epidemiol. 2015; 39: 1-7
- The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis.Eur J Cancer. 2009; 45: 909-930
- Cancer prevalence estimates in Europe at the beginning of 2000.Ann Oncol. 2013; 24: 1660-1666
- Progress against cancer in the Netherlands since the late 1980s: an epidemiological evaluation.Int J Cancer. 2012; 130: 2981-2989
IARC, WHO. European code against cancer - Fourth edition, 14 October 2014. Available at: <http://cancer-code-europe.iarc.fr>.